Keith Goldan
Finanzdirektor/CFO bei SYNDAX PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 31.05.2024
Aktive Positionen von Keith Goldan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SYNDAX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 05.05.2023 | - |
Finanzdirektor/CFO | 13.06.2022 | - | |
Treasurer | 13.06.2022 | - |
Karriereverlauf von Keith Goldan
Ehemalige bekannte Positionen von Keith Goldan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OPTINOSE, INC. | Finanzdirektor/CFO | 01.01.2017 | 10.06.2022 |
FIBROCELL SCIENCE, INC. | Finanzdirektor/CFO | 18.03.2015 | 01.01.2017 |
Unternehmenssekretär | 18.03.2015 | 17.06.2015 | |
Treasurer | 18.03.2015 | 01.01.2017 | |
NUPATHE INC | Finanzdirektor/CFO | 04.05.2009 | 21.02.2014 |
Investor Relations Kontakt | 22.03.2011 | 21.02.2014 | |
Public Communications Contact | 15.02.2011 | 21.02.2014 | |
Cantel Medical (UK) Ltd.
Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Finanzdirektor/CFO | - | 31.10.2008 |
REALM THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.10.2004 | 13.10.2008 |
Finanzdirektor/CFO | 01.10.2004 | 13.10.2008 | |
Century Capital Associates | Gründer | - | - |
Mitglied des Investmentausschusses | - | 21.06.2011 | |
Corporate Officer/Principal | - | - | |
Biosyn, Inc.
Biosyn, Inc. Pharmaceuticals: MajorHealth Technology Biosyn, Inc. operates as a pharmaceutical company that develops and commercializes drugs used to treat infectious disease and reproductive health. The company is headquartered in Philadelphia, PA. | Finanzdirektor/CFO | - | - |
Ausbildung von Keith Goldan
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Robert H. Smith School of Business | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 7 |
Treasurer | 2 |
Director/Board Member | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
OPTINOSE, INC. | Health Technology |
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Cantel Medical (UK) Ltd.
Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Retail Trade |
Realm Therapeutics Plc
Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
Biosyn, Inc.
Biosyn, Inc. Pharmaceuticals: MajorHealth Technology Biosyn, Inc. operates as a pharmaceutical company that develops and commercializes drugs used to treat infectious disease and reproductive health. The company is headquartered in Philadelphia, PA. | Health Technology |
NuPathe, Inc.
NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
Century Capital Associates | |
Fibrocell Science, Inc.
Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA. | Health Technology |
- Börse
- Insiders
- Keith Goldan
- Erfahrung